# =============================================================================
# ESTADO DEL SISTEMA - Value Investor v3.0
# Actualizado 2026-02-04
# =============================================================================

system:
  system_version: "3.0.0"
  framework_version: "3.0"
  last_session: 2026-02-05
  session_number: 32

  # FRAMEWORK v3.0 - IMPLEMENTADO
  # =====================================
  framework_v3_status:
    status: IMPLEMENTED
    document: docs/framework_v3.0_final_design.md
    implementation_date: 2026-02-04
    key_changes:
      - "Quality Score (0-100) ANTES de valoración"
      - "MoS variable: Tier A 10-15%, Tier B 20-25%, Tier C 30-40%"
      - "Tier D (<35 QS) = NO COMPRAR nunca"
      - "Métodos: OEY + Reverse DCF para Tier A"
      - "9 Gates en Investment Committee"
    phases:
      - phase: 1
        name: "Core System Update"
        status: COMPLETED
        description: "CLAUDE.md, investment-rules, quality-compounders skill, business-analysis-framework, valuation-methods"
      - phase: 2
        name: "Agents & Tools"
        status: COMPLETED
        description: "fundamental-analyst, investment-committee, quality_scorer.py"
      - phase: 3
        name: "Portfolio Re-evaluation"
        status: COMPLETED
        description: "Quality Score calculado para 18 posiciones"
      - phase: 4
        name: "Pipeline Expansion"
        status: PENDING
        description: "Añadir Quality Compounders a watchlist"
      - phase: 5
        name: "Validation"
        status: PENDING
        description: "Review +30 días"

  # QUALITY SCORE - PORTFOLIO ANALYSIS (2026-02-04)
  # ===============================================
  portfolio_quality_analysis:
    date: 2026-02-05
    summary:
      tier_a_count: 2  # ADBE + NVO
      tier_b_count: 5
      tier_c_count: 12
      tier_d_count: 0
      tier_d_violation: null  # RESOLVED: FUTR.L sold 2026-02-04
      first_tier_a: ADBE  # First Quality Compounder in portfolio!
      framework_v3_validated: true  # NVO = full end-to-end validation
    positions:
      # TIER A - Quality Compounders (2 positions)
      - { ticker: ADBE, score: 76, tier: A, mos_required: "10-15%", status: "First Tier A!" }
      - { ticker: NVO, score: 82, tier: A, mos_required: "10-15%", status: "Framework v3.0 validated! MoS 38%" }
      # TIER B - Quality Value (5 positions)
      - { ticker: HRB, score: 73, tier: B, mos_required: "20-25%" }
      - { ticker: EDEN.PA, score: 62, tier: B, mos_required: "20-25%" }
      - { ticker: DOM.L, score: 61, tier: B, mos_required: "20-25%" }
      - { ticker: SAN.PA, score: 59, tier: B, mos_required: "20-25%" }
      - { ticker: LIGHT.AS, score: 56, tier: B, mos_required: "20-25%" }
      # TIER C - Special Situations (12 positions)
      - { ticker: ALL, score: 54, tier: C, mos_required: "30-40%" }
      - { ticker: VICI, score: 54, tier: C, mos_required: "30-40%" }
      - { ticker: IMB.L, score: 54, tier: C, mos_required: "30-40%" }
      - { ticker: GL, score: 52, tier: C, mos_required: "30-40%" }
      - { ticker: UHS, score: 51, tier: C, mos_required: "30-40%" }
      - { ticker: PFE, score: 49, tier: C, mos_required: "30-40%" }
      - { ticker: DTE.DE, score: 48, tier: C, mos_required: "30-40%" }
      - { ticker: TEP.PA, score: 46, tier: C, mos_required: "30-40%" }
      - { ticker: TATE.L, score: 45, tier: C, mos_required: "30-40%" }
      - { ticker: VNA.DE, score: 41, tier: C, mos_required: "30-40%" }
      - { ticker: A2A.MI, score: 37, tier: C, mos_required: "30-40%" }
      - { ticker: SHEL.L, score: 36, tier: C, mos_required: "30-40%" }
      # TIER D - NONE (FUTR.L sold 2026-02-04)
    diagnosis: |
      Portfolio evolucionando de v2.0 (P/E screening) a v3.0 (Quality First).
      Sesión 31: FUTR.L vendido (Tier D), ADBE comprado (primer Tier A).
      Ahora: 1 Tier A, 5 Tier B, 12 Tier C. Sin violaciones Tier D.
      Continuar añadiendo Tier A compounders: NOVO-B.CO, MA, V en pipeline.
  last_session_summary: |
    Sesión 32 - FRAMEWORK v3.0 VALIDADO + SEGUNDO TIER A (2026-02-05)

    =====================================================
    HITO: Framework v3.0 validado end-to-end con NVO
    =====================================================

    OPERACIONES EJECUTADAS:
    1. BUY NVO 8.31 shares @ $48.13 = $400
       - QS: 82/100 (Tier A - Quality Compounder)
       - MoS: 38% (excepcional)
       - Framework v3.0 completo: QS → Business → Projections → Valuation → 9 Gates
       - Segundo Tier A en portfolio (ADBE + NVO)

    ANÁLISIS COMPLETADOS:
    1. MA (Mastercard) - QS 86 Tier A - WATCHLIST
       - Overvalued: $551 actual vs $420 FV
       - Entry price: $395 (-28%)
       - Standing order añadido

    2. Sector view payments-fintech CREADO
       - Duopolio V/MA documentado
       - Prerequisito para análisis MA/V

    SISTEMA:
    1. opportunity-hunter verificado y añadido a agent-registry
    2. Standing orders verificados:
       - EVO.ST TRIGGERED (581 < 600) pero condicionado a earnings mañana
       - ZIG.L -3.4% del trigger (388 vs 375)

    PORTFOLIO:
    | Métrica | Valor |
    |---------|-------|
    | Posiciones | 19 |
    | Tier A | 2 (ADBE, NVO) |
    | Cash | €1,773 (18%) |
    | Standing orders | 12 |

    =====================================================
    ACCIONES PENDIENTES PRÓXIMA SESIÓN
    =====================================================

    URGENTE:
    1. Evaluar EVO.ST earnings (Feb 5) - standing order condicionado
    2. Monitorear ZIG.L (-3.4% del trigger)
    3. Evaluar earnings GL, ALL, SHEL

    ALTA PRIORIDAD:
    4. Continuar desplegando cash (18% → 15%)
    5. Analizar V (Visa) si interesa - pero probablemente también overvalued

    CALENDARIO PRÓXIMOS 7 DÍAS:
    - Feb 5: EVO.ST earnings, GL call, ALL earnings, SHEL earnings
    - Feb 11: CVS earnings
    - Feb 12: BATS.L earnings

    =====================================================

  last_session_summary_archived: |
    Sesión 31 - PRIMER QUALITY COMPOUNDER + CONSTRAINTS RESUELTOS (2026-02-04)

    =====================================================
    HITO: ADBE = Primer Tier A en Portfolio
    =====================================================

    OPERACIONES EJECUTADAS:
    1. SELL FUTR.L 111 shares @ 522.50 GBp
       - P&L: -€23 (-2.8%)
       - Razón: Tier D violation (QS 32/100)
       - Framework v3.0 funcionando: no toleramos Tier D

    2. BUY ADBE 2 shares @ $270.60
       - Total: $541.20 (~€458)
       - QS: 76/100 (Tier A - Quality Compounder)
       - MoS: 31% (vs 20% requerido)
       - FV: $394 (OEY + Reverse DCF)
       - At 52-week low, P/E 16.3x excepcional

    3. TRIM DTE.DE 3 shares @ €30.31
       - Proceeds: €91
       - Constraint 7.3% → 6.4% RESOLVED

    PORTFOLIO ACTUAL:
    | Tier | Count | Posiciones |
    |------|-------|------------|
    | A    | 1     | ADBE (NEW!) |
    | B    | 5     | HRB, EDEN, DOM, SAN, LIGHT |
    | C    | 12    | ALL, VICI, IMB, GL, UHS, PFE, DTE, TEP, TATE, VNA, A2A, SHEL |
    | D    | 0     | NINGUNA (FUTR.L vendido) |

    MÉTRICAS:
    - Posiciones: 18
    - Valor: $11,503 (€9,727)
    - P&L: +$171 (+1.9%)
    - Cash: €2,112 (21.7%)
    - Constraints: TODOS OK

    EARNINGS FRAMEWORKS PREPARADOS (Feb 5):
    - GL: Q4 after-close, consensus EPS $3.44
    - ALL: Q4, watch combined ratio
    - SHEL.L: Q4, watch FCF y buyback
    Decision trees listos para cada escenario.

    =====================================================
    ACCIONES PENDIENTES PRÓXIMA SESIÓN
    =====================================================

    URGENTE:
    1. Evaluar resultados earnings GL, ALL, SHEL.L
    2. Continuar desplegando cash (21.7% → 15% target)

    ALTA PRIORIDAD:
    3. Analizar NOVO-B.CO (QS 94, near 52w low)
    4. Analizar MA (QS 86, at 52w low)
    5. Monitorear ZIG.L standing order (-3% del trigger)

    PIPELINE:
    6. Phase 4 en progreso: añadiendo Quality Compounders
    7. Phase 5 en 30 días: validar resultados

    =====================================================
    ESTADO DEL SISTEMA
    =====================================================
    - Framework: v3.0 OPERATIVO
    - Tier D violations: 0 (resuelto)
    - Primer Tier A: ADBE
    - Standing orders: 9 activas
    - Próximo health check: 2026-02-18

    ARCHIVOS MODIFICADOS:
    - portfolio/current.yaml (FUTR.L removed, ADBE added, DTE.DE trimmed)
    - portfolio/history.yaml (FUTR.L closed position)
    - thesis/archive/FUTR.L/ (moved from active)
    - thesis/active/ADBE/ (new)
    - state/system.yaml (calendar, quality analysis)

  status: active

# -----------------------------------------------------------------------------
# CALENDARIO
# -----------------------------------------------------------------------------
calendar:
  events:
    # WEEK OF FEB 3-7
    - date: 2026-02-03
      type: action_completed
      ticker: SHEL
      event: "DONE - TRIM SHEL: vender 10 acciones"
      priority: CRITICAL
      action: "SELL 10 shares SHEL en eToro. 20.85-10.85. Rebalanceo 13%-7%."

    - date: 2026-02-03
      type: action_completed
      ticker: A2A.MI
      event: "DONE - BUY A2A.MI ~134 shares"
      priority: CRITICAL
      action: "BUY ~134 shares A2A.MI ~2.54. Total ~340 (4%). Max entry 2.80."

    - date: 2026-02-03
      type: action_completed
      ticker: EDEN.PA
      event: "DONE - BUY EDEN.PA ~22 shares"
      priority: CRITICAL
      action: "BUY ~22 shares EDEN.PA ~17.67. Total ~400 (4%). FV 33-36."

    - date: 2026-02-03
      type: action_completed
      ticker: VNA.DE
      event: "DONE - BUY VNA.DE ~16 shares"
      priority: CRITICAL
      action: "BUY ~16 shares VNA.DE ~24.61. Total ~400 (4%). FV 35-38."

    - date: 2026-02-03
      type: earnings_completed
      ticker: PFE
      event: "DONE - Pfizer Q4 2025: BEAT EPS $0.66 vs $0.57, guidance reaffirmed"
      priority: high
      action: "HOLD - MoS 8.7%, dividend maintained. No action needed."

    - date: 2026-02-03
      type: action_completed
      ticker: TEP.PA
      event: "DONE - TRIM TEP.PA: sold 3 shares"
      priority: high
      action: "Sold 3 shares @ 53.14 = 159. Position 7.8%-6.1%. Constraint resolved."

    - date: 2026-02-03
      type: analysis_completed
      ticker: HPQ
      event: "HPQ RE-EVALUATED v2.0: REJECTED as value trap"
      priority: high
      action: "Standing order ELIMINATED. Thesis archived. 4/10 value trap factors, MoS 22% vs 35% required."

    - date: 2026-02-03
      type: analysis_completed
      ticker: UTG.L
      event: "UTG.L RE-EVALUATED v2.0: Standing order VALIDATED at 540 GBp"
      priority: high
      action: "FV updated 745p (was 770p). MoS at 540p = 27.5%. Tier B REIT. Value trap 1.5/10."

    - date: 2026-02-04
      type: action_completed
      ticker: FUTR.L
      event: "DONE - SOLD FUTR.L 111 shares (Tier D violation resolved)"
      priority: CRITICAL
      action: "SOLD 111 shares FUTR.L @ 522.50 GBp. P&L -2.8% (-€23). Cash +€672. Capital ready for quality compounders."

    - date: 2026-02-04
      type: action_completed
      ticker: ADBE
      event: "DONE - BUY ADBE 2 shares (First Tier A Quality Compounder!)"
      priority: high
      action: "BUY 2 shares ADBE @ $270.60. Total $541.20. QS 76, MoS 31%. At 52w low. FV $394."

    - date: 2026-02-05
      type: earnings
      ticker: GL
      event: "Globe Life Q4 2025 (after market close)"
      priority: high
      action: "Watch: EPS $3.44 consensus, FY2026 guidance. If beat - may re-rate. If miss - evaluate position. MoS at $143 = 17.6%."

    - date: 2026-02-05
      type: earnings
      ticker: ALL
      event: "Allstate Q4 2025"
      priority: high
      action: "Watch combined ratio Q4, guidance 2026 mid-90s, PIF growth."

    - date: 2026-02-05
      type: earnings
      ticker: SHEL.L
      event: "Shell Q4 2025"
      priority: high
      action: "Watch FCF, buyback $3.5B, guidance."

    - date: 2026-02-05
      type: action_completed
      ticker: NVO
      event: "DONE - BUY NVO 8.31 shares (Second Tier A Quality Compounder!)"
      priority: high
      action: "BUY 8.31 shares NVO @ $48.13. Total $400. QS 82 Tier A, MoS 38%. Framework v3.0 validated. Phased entry 4%."

    - date: 2026-02-05
      type: action
      ticker: EVO.ST
      event: "POST-EARNINGS: Evaluar compra Evolution AB"
      priority: high
      action: "Si buenos + UKGC OK - BUY hasta 650 SEK (~400). Si malos - 480-530 SEK. Si UKGC revocacion - DESCARTAR."

    - date: 2026-02-05
      type: standing_order_alert
      ticker: ZIG.L
      event: "ZIG.L -3.4% del trigger (388 GBp vs 375 GBp)"
      priority: high
      action: "MONITOR DIARIO. Si llega a 375 GBp - EJECUTAR standing order (350 EUR, 81 shares)."

    - date: 2026-02-05
      type: standing_order_alert
      ticker: EVO.ST
      event: "EVO.ST BAJO trigger (581 SEK < 600 SEK) pero CONDICIONADO"
      priority: high
      action: "ESPERAR earnings Feb 5. Si UKGC favorable + resultados OK - EJECUTAR. Si UKGC revocación - CANCELAR."

    - date: 2026-03-15
      type: catalyst
      ticker: NVO
      event: "CagriSema vs Zepbound head-to-head data (critical catalyst)"
      priority: CRITICAL
      action: "If positive: ADD 2% to NVO position. If inferior: evaluate kill conditions."

    - date: 2026-02-03
      type: action_completed
      ticker: TATE.L
      event: "DONE - BUY TATE.L 66 shares"
      priority: high
      action: "Bought 66 shares TATE.L, $339.73 invested. Starter position 2.7%."

    - date: 2026-02-02
      type: action_completed
      ticker: DOM.L
      event: "DONE - BUY DOM.L 175 shares"
      priority: high
      action: "Bought 175 shares DOM.L, $436.52 invested. Master franchisee, 54% UK market share."

    - date: 2026-02-24
      type: earnings
      ticker: UTG.L
      event: "Unite Group FY2025 Preliminary Results"
      priority: high
      action: "Watch: FY2026 guidance, occupancy FY2027 reservations, Empiric synergies. If occupancy >95% - may trigger early. If <93% - lower trigger to 500p."

    - date: 2026-03-05
      type: earnings
      ticker: DOM.L
      event: "Dominos Pizza Group FY25 results"
      priority: high
      action: "Review EBITDA guidance, FCF, dividend policy, CEO appointment timeline. Kill conditions: ND/EBITDA >3x, FCF <60M, share <45%."

    - date: 2026-02-02
      type: action_completed
      ticker: UHS
      event: "DONE - BUY UHS 2 shares"
      priority: high
      action: "Bought 2 shares UHS, $402.84 invested. Behavioral health leader, P/E 9.6x."

    - date: 2026-02-26
      type: earnings
      ticker: UHS
      event: "UHS Q4 2025 / FY2025 earnings (estimated)"
      priority: high
      action: "Watch: EPS vs $21.80 consensus, behavioral health volumes, labor costs, Medicaid impact. Kill: ROIC<WACC 2Q, BH volumes decline YoY."

    - date: 2026-02-04
      type: action_cancelled
      ticker: HRB
      event: "CANCELLED - HRB ADD order was ERROR (price $27.90 unrealistic)"
      priority: low
      action: "Original order deleted. ADD trigger per thesis is <$35. Current price $37.20 = no action. Monitor for dip."

    - date: 2026-02-07
      type: action_completed
      ticker: DTE.DE
      event: "TRIM DTE.DE ejecutado 2026-02-03: vendidas 14 shares, posicion reducida a 7%"

    - date: 2026-02-11
      type: earnings
      ticker: CVS
      event: "CVS Health Q4 2025"
      priority: high
      action: "BEAT (EPS >$6.70, margin >8%) - ready_to_buy 300. MISS - descartar."

    - date: 2026-02-19
      type: earnings
      ticker: AGN.NV
      event: "Aegon FY2025"
      priority: high
      action: "Watch OCG 1.2B, solvency >180%. Si precio cae 5.90 - BUY."

    - date: 2026-02-23
      type: strategy
      ticker: ENEL.MI
      event: "Enel Capital Markets Day"
      priority: high
      action: "Si FV sube 11-12 - entry 8.50."

    - date: 2026-02-26
      type: earnings
      ticker: DTE.DE
      event: "Deutsche Telekom FY2025"
      priority: high
      action: "Watch FCF, EBITDA, guidance 2026."

    - date: 2026-02-26
      type: earnings
      ticker: CS.PA
      event: "AXA FY2025 results"
      priority: high
      action: "Si precio cae a 34.50-35.50 post-earnings - BUY 5% (~500). Combined ratio <90% + guidance OK = compra."

    - date: 2026-02-27
      type: earnings
      ticker: PROX.BR
      event: "Proximus FY2025 + Strategic Plan"
      priority: high
      action: "Si capex decline confirmado + plan Global creible - BUY 3% (~300) a 7.50-7.70. Si decepcionante - AVOID hasta 5-6."

    - date: 2026-02-28
      type: earnings
      ticker: ENGI.PA
      event: "Engie FY2025"
      priority: high
      action: "Watch FCF yield >5%, payout <80%, Debt/EBITDA <4x."

    - date: 2026-03-01
      type: earnings
      ticker: NTGY.MC
      event: "Naturgy FY2025"
      priority: high
      action: "Watch dividend, FCF, Debt/EBITDA <4x."

    - date: 2026-03-19
      type: earnings
      ticker: ENEL.MI
      event: "Enel FY2025 results"
      priority: medium

# -----------------------------------------------------------------------------
# WATCHLIST
# -----------------------------------------------------------------------------
watchlist:
  # QUALITY COMPOUNDERS PIPELINE (Framework v3.0 - Tier A)
  quality_compounders:
    # NOVO-B.CO/NVO MOVED TO PORTFOLIO 2026-02-05
    # MA ANALYZED 2026-02-05 - WATCHLIST (overvalued)
    - ticker: MA
      quality_score: 86
      tier: A
      current_price_usd: 551
      fair_value_usd: 420
      entry_price_usd: 395
      mos_current: "-24% (OVERVALUED)"
      mos_required: "10-15%"
      status: "WATCHLIST - Wait for $395 (-28% from current)"
      notes: "QS 86 confirmed. ROIC 44%, FCF 48%. Wide moat. But P/E 33x needs correction to P/E 24-28x."
    - ticker: V
      quality_score: 80
      tier: A
      current_price_usd: 329
      fair_value_usd: 275-290
      entry_price_usd: 280
      entry_price_add: 265
      mos_current: "-12.6% (OVERVALUED)"
      mos_required: "10-15%"
      status: "WATCHLIST - Wait for $280 (-15% from current)"
      notes: "QS 80 confirmed. ROIC 50%+, FCF 54%, #1 share 52%. Standing order $280 BUY, $265 ADD."
    - ticker: ADBE
      quality_score: 76
      tier: A
      current_price_usd: 272
      at_52w_low: true
      mos_required: "10-15%"
      status: "ANALYZE PRIORITY - At 52w low, AI beneficiary"
      notes: "P/E 16.3x ONLY! -51% from 52wH. Creative monopoly + AI. Low cap alloc score."
    - ticker: GOOGL
      quality_score: 76
      tier: A
      current_price_usd: 340
      mos_required: "10-15%"
      status: "ANALYZE - Near 52w high, wait for pullback"
      notes: "P/E 33.6x. Search + Cloud + YouTube moat."

  # QUALITY VALUE (Framework v3.0 - Tier B)
  quality_value:
    - ticker: META
      quality_score: 74
      tier: B
      current_price_usd: 692
      mos_required: "20-25%"
      notes: "P/E 29.4x. -27% from 52wH. Social moat + AI."
    - ticker: ASML
      quality_score: 66
      tier: B
      mos_required: "20-25%"
      notes: "Lithography monopoly. Wait for analysis."

  ready_to_buy:
    - ticker: TTE
      target_entry_eur: 45
      fair_value_eur: 60-83
      margin_of_safety: 26%
      sizing: "1,170 (7%)"
      status: "WAIT - current ~61 = 0% MoS. Need earnings + correction."
      thesis: thesis/watchlist/TTE/thesis.md

    - ticker: LGEN.L
      target_entry_gbp: 215
      sizing: "1,170 (7%)"
      status: "ON WATCH - wait FY2025 results"
      notes: "P/E ~10x, yield 8.5%, BofA 17.5% capital return"

    - ticker: EVO.ST
      target_entry_sek: 480-650
      fair_value_sek: 1009
      margin_of_safety: 42.6%
      sizing: "400 (4%)"
      status: "WAIT earnings 5-feb"
      thesis: thesis/research/EVO.ST/thesis.md


  tier_2:
    - ticker: AGN.NV
      entry: "5.90-6.10"
      notes: "P/E 7.4x, yield 5.8%. Borderline MoS. Earnings 19-Feb."
    - ticker: MBG.DE
      entry: "48-52"
      notes: "Current 57. Need 30%+ MoS. Q4 earnings catalyst."
    - ticker: CS.PA
      entry: "34.50-35.50"
      notes: "AXA. Tier A (8/10). FV 40.50. Wide moat. Solvency 222%. WAIT FY2025 earnings 26-feb."
    - ticker: ORA.PA
      entry: "13-14"
      notes: "Orange. Current 15.62 above old target. P/E 41x = expensive. Needs re-evaluation or REMOVE."
    - ticker: RIO.L
      entry: "120"
      notes: "Materials diversification. Lithium pivot."
    - ticker: ENGI.PA
      entry: "22"
      notes: "Yield 6.6%. Needs fundamental analysis."
    - ticker: NTGY.MC
      entry: "19-21"
      notes: "Yield conflict. Needs data validation."
    - ticker: CMCSA
      entry: "$25-26"
      notes: "FV $33-38 (adjusted for normalized FCF + $90B debt). Broadband moat ERODING (FWA, fiber). Peacock -$500M/Q. Theme parks bright spot. NO BUY at $29.75."
    - ticker: GIS
      entry: "$34-38"
      notes: "DCF ~$41. D/E 147%, GLP-1 headwind."
    - ticker: AZM.MI
      entry: "32-33"
      notes: "Asset manager. P/E 9.8x, yield 4.9%, D/E 0.01. Narrow moat. FV 42-44. Strong buy 30."
    - ticker: PROX.BR
      entry: "7.50-7.70"
      notes: "Telecom belga. EV/EBITDA 3.1x. FV 12 base. WAIT strategic plan 27-feb. DIGI risk."

  on_watch:
    - ticker: ENEL.MI
      entry: "7.00-7.50"
      notes: "Vendida breakeven. CMD 23-feb catalyst."
    - ticker: CVS
      entry: "$70"
      notes: "Turnaround. Q4 11-feb binary event."
    - ticker: AMT
      entry: "$160-165"
      notes: "Infrastructure REIT. Debt/EBITDA 6.18x."
    - ticker: IBE.MC
      entry: "14-15"
      notes: "Quality but P/E 21-24x premium."
    - ticker: ADM.L
      entry: "24-26"
      notes: "ROE 56% but margin -16%."
    - ticker: 8001.T
      entry: "6,500 ($43)"
      notes: "Itochu. Quality premium in price."
    - ticker: TATE.L
      entry: "375 GBp (starter BOUGHT), 350 GBp add, 325 GBp full position"
    - ticker: BME.L
      entry: "169 GBp"
      notes: "B&M discount retail. FV 260p. At 169p = 35% MoS Tier C. Or wait H2 June 2026. D/E high (IFRS16). Narrow moat."
    - ticker: TBCG.L
      entry: "3500 GBp"
      notes: "TBC Bank Georgia. ROE 24%, P/E 6.6x. MoS 21% at 4265 = FAIL Tier C. At 3500 = 35% MoS. Max 4%. Frontier risk."
    - ticker: BGEO.L
      entry: "7000 GBp"
      notes: "Lion Finance (ex-Bank of Georgia). P/E 7.9x, ROE 29%. Near 52w high (9975 vs 10230). NO discount. Wait -30% correction. Same Georgia risk as TBCG."
    - ticker: WPP.L
      entry: "200 GBp"
      notes: "v2.0: Probable value trap (5-6/10). FV 380p. MoS 28% vs 35% required. Standing order 200p = 47% MoS. Wait Rose plan Feb 19."
    - ticker: UTG.L
      entry: "540 GBp"
      fair_value: "745 GBp"
      fair_value_v2: "745p (central), Bear 610p, Bull 870p"
      notes: "v2.0 RE-EVAL: MoS at 540p = 27.5% (PASSES 25% Tier B). FY2026 earnings trough -7-10%. 42% discount to NAV 986p. Near-monopoly UK listed PBSA. Value trap 1.5/10. Earnings Feb 24."
      kill: "Occupancy <90%, dividend cut, LTV >35%, immigration policy kills int'l student demand"
    - ticker: MEGP.L
      entry: "131 GBp"
      fair_value: "175 GBp"
      notes: "ME Group. ROE 31.8%, EBITDA margin 37%, net cash, monopoly laundry kiosks. Only 2 analysts. At 131p = 25% MoS. FY2025 results mid-Feb catalyst."
      kill: "German photo regulation kills Photo.ME division, laundry growth stalls <10%"

  archived_rejected:
    - ticker: HPQ
      rejection_date: 2026-02-03
      reason: "VALUE TRAP - 4/10 trap factors (secular printing decline, digital disruption, negative equity, heavy insider selling). MoS 22% vs 35% required for Tier C. CEO departed. No moat. Thesis archived."
      fair_value: "$21-24"
      entry_would_need: "$15.35 (for 35% MoS)"
      thesis: thesis/archive/HPQ/thesis.md

    - ticker: MEGP.L
      rejection_date: 2026-02-03
      reason: "NOT AVAILABLE ON ETORO - Excellent company (ROE 31.8%, MoS 29%, value trap 0.5/10) but broker doesn't offer this LSE micro-cap. Consider if switching brokers."
      fair_value: "195 GBp"
      thesis: thesis/archive/MEGP.L/thesis.md

    - ticker: CAG
      rejection_date: 2026-02-04
      reason: "VALUE TRAP 5/10 - Q2 FY26 loss $664M, impairment $968M, ROIC 5.3% barely covers WACC, dividend payout -667% (paying from losses). Worst margins in sector. GIS is better choice if want food exposure."
      fair_value: "$17.50 (current $19.11 = overvalued)"
      thesis: thesis/research/CAG/thesis.md

  active_monitoring:
    - ticker: A2A.MI
      entry: 2.548
      fair_value: 3.62
      kill: "FCF decline >15% or dividend cut"
    - ticker: EDEN.PA
      entry: 17.61
      fair_value: 33-36
      kill: "FCF <300M or revenue decline >10%"
    - ticker: VNA.DE
      entry: 24.55
      fair_value: 35-38
      kill: "FFO/share decline >15% or dividend cut"
    - ticker: DTE.DE
      entry: 31.85
      fair_value: 58-74
      kill: "T-Mobile US spin-off fails or EBITDA decline >10%"
    - ticker: SHEL.L
      entry_usd: 36.72
      fair_value_usd: 45-55
      kill: "Dividend cut or FCF <$20B sustained"
    - ticker: PFE
      entry_usd: 26.75
      fair_value_usd: 32-35
      kill: "Dividend cut or FY2026 guidance miss >10%"
    - ticker: ALL
      entry_usd: 196.00
      fair_value_usd: 240-260
      kill: "Combined ratio >100% sustained or catastrophe losses >$5B"
    - ticker: TEP.PA
      entry: 54.60
      fair_value: 115
      kill: "FCF <600M or revenue -5%"
    - ticker: SAN.PA
      entry: 79.20
      fair_value: 95-105
      kill: "Dividend cut or 2+ trial failures"
    - ticker: VICI
      entry_usd: 28.08
      fair_value_usd: 34-35
      kill: "Dividend cut or tenant bankruptcy"
    - ticker: IMB.L
      entry_usd: 42.34
      fair_value_usd: 44-52
      kill: "Dividend cut or buyback suspension"
    - ticker: LIGHT.AS
      entry: 17.91
      fair_value: 26.73
      kill: "FCF <300M or revenue -10%"
    - ticker: TATE.L
      entry: 375
      fair_value: 500
      kill: "Dividend cut, ND/EBITDA >3x, EBITDA margin <17%"
    - ticker: DOM.L
      entry: 183
      fair_value: 260-280
      kill: "Net Debt/EBITDA >3x, FCF <60M, market share <45%, dividend cut"
    - ticker: UHS
      entry_usd: 201.42
      fair_value_usd: 270-313
      kill: "ROIC < WACC 2 consecutive quarters, behavioral health volumes decline YoY, Medicaid cuts >$100M"
    - ticker: GL
      entry_usd: 141.06
      fair_value_usd: 174
      fair_value_original: 215
      fair_value_v2: 174
      mos_v2: 17.6%
      notes: "Framework v2.0 re-eval: P/B vs ROE + P/E normalized. 0/10 value trap. Beta 0.46. Quality 7/10 Tier B. MoS below 25% threshold - HOLD, no ADD."
      kill: "Operating EPS <$12, or class action reveals material new fraud evidence"
      buy_trigger: "$130 or below (MoS would be 25.3%)"
    - ticker: FUTR.L
      entry_gbp: 532
      fair_value_gbp: 1100-1200
      kill: "Revenue decline >10% 2+ years, margins <20%, buyback suspension"
    - ticker: NVO
      entry_usd: 48.13
      fair_value_dkk: 491
      fair_value_usd: 66  # approx, DKK 491 / 7.45
      mos: 38%
      tier: A
      quality_score: 82
      notes: "Framework v3.0 validated. Phased entry 4%. ADD trigger: CagriSema positive (Mar 2026) or price <$40."
      kill: "CagriSema inferior to Zepbound, market share <40%, gross margin <70%, dividend cut"

# -----------------------------------------------------------------------------
# ALERTAS DE PRECIO
# -----------------------------------------------------------------------------
alerts:
  price_monitors:
    - { ticker: TTE, entry_eur: 45, note: "FV 60. Wait earnings+correction" }
    - { ticker: LGEN.L, entry_gbp: 215, note: "FV ~265p. Wait FY2025" }
    - { ticker: MBG.DE, entry_eur: 50, note: "FV 70. Cyclical wait" }
    - { ticker: ENEL.MI, entry_eur: 7.50, note: "Re-entry. CMD 23-feb" }
    - { ticker: AGN.NV, entry_eur: 5.90, note: "Borderline. Earnings 19-Feb" }
    - { ticker: CVS, entry_usd: 70, note: "Q4 11-feb binary" }
    - { ticker: T, entry_usd: 22.50, note: "FCF $18B+. Best US telecom" }
    - { ticker: BNP.PA, entry_eur: 78, note: "FV 103. CET1 12.5%" }
    - { ticker: ENGI.PA, entry_eur: 22, note: "FV 29. Yield 6%" }
    - { ticker: CS.PA, entry_eur: 35.50, note: "AXA. FV 40.50. Tier A. Earnings 26-feb" }
    - { ticker: BME.L, entry_gbp: 169, note: "B&M Retail. FV 260p. Tier C turnaround." }
    - { ticker: TBCG.L, entry_gbp: 3500, note: "TBC Bank Georgia. FV 5400p. Frontier Tier C." }
    - { ticker: BGEO.L, entry_gbp: 7000, note: "Lion Finance (ex-BOG). Near ATH, wait correction." }
    - { ticker: WPP.L, entry_gbp: 200, note: "v2.0: 5-6/10 trap. FV 380p. 47% MoS at trigger. Feb 19 Rose plan critical." }
    - { ticker: TATE.L, entry_gbp: 350, note: "ADD to starter. FV 500p. Already own 66 shares." }
    - { ticker: DGE.L, entry_gbp: 1300, note: "Diageo v2.0: FV 1400-1520 GBp. OVERVALUED at 1690. Entry 1300 for 15% MoS." }
    - { ticker: EVO.ST, entry_sek: 530, note: "Evolution. If Q4 miss - buy 480-530 SEK." }
    - { ticker: GL, entry_usd: 130, note: "Globe Life ADD trigger. At $130 MoS=25.3%. Do not add >$130." }
    - { ticker: UTG.L, entry_gbp: 540, note: "v2.0 VALIDATED. FV 745p. At 540p MoS 27.5%. Earnings Feb 24." }
    - { ticker: SRE.L, entry_gbp: 75, note: "Sirius RE. FV 100p. Entry 75p = 25% MoS. Refinancing Jun-2026 catalyst." }
    - { ticker: GIS, entry_usd: 38, note: "General Mills. FV $45-50. Entry $35-38. Quality 6.5/10 Tier B. GLP-1 headwind." }
    - { ticker: BATS.L, entry_gbp: 4200, note: "BAT. FV 5163p. Entry 4000-4200p. Ya tenemos IMB.L. Earnings 12-feb." }
    - { ticker: V, entry_usd: 280, note: "Visa. QS 80 Tier A. FV $275-290. Entry $280, ADD $265. Duopoly #1." }

# -----------------------------------------------------------------------------
# STANDING ORDERS (pre-aprobadas, ejecutar cuando precio toque trigger)
# El humano puede ejecutar en eToro sin esperar sesion.
# En siguiente sesion confirma y se actualiza portfolio.
# -----------------------------------------------------------------------------
standing_orders:
  # THESIS COMPLETA + COMMITTEE APROBADO - Solo falta que precio llegue
  - ticker: BME.L
    action: BUY
    trigger: "<=169 GBp"
    size_eur: 400
    shares_approx: 235
    thesis: thesis/research/BME.L/thesis.md
    fair_value: "321 GBp"
    mos_at_trigger: "47%"
    notes: "B&M discount retail. v2.0 CONFIRMED. Tier C. Value trap 2/10. EV/EBIT + DCF multi-method."
    expiry: 2026-04-01

  # MEGP.L REMOVED 2026-02-03 - NOT AVAILABLE ON ETORO
  # Was: trigger 145 GBp, FV 195 GBp, MoS 29%. Excellent company but broker doesn't offer it.
  # See thesis/archive/MEGP.L/

  - ticker: UTG.L
    action: BUY
    trigger: "<=540 GBp"
    size_eur: 400
    shares_approx: 64
    thesis: thesis/research/UTG.L/thesis_v2.md
    fair_value: "745 GBp"
    fair_value_bear: "610 GBp"
    fair_value_bull: "870 GBp"
    mos_at_trigger: "27.5%"
    tier: "B (Asset-Heavy REIT)"
    value_trap_score: "1.5/10"
    moat: "Narrow (Efficient Scale - near monopoly UK listed PBSA)"
    notes: "v2.0 RE-EVAL VALIDATED. 42% discount NAV. FY2026 earnings trough -7-10%. Multi-method: NAV+DDM+FFO. Earnings Feb 24."
    kill_conditions: "Occupancy <90%, dividend cut, LTV >35%, immigration policy kills demand"
    expiry: 2026-04-01

  - ticker: TATE.L
    action: ADD
    trigger: "<=350 GBp"
    size_eur: 350
    shares_approx: 87
    thesis: thesis/active/TATE.L/thesis.md
    fair_value: "500 GBp"
    mos_at_trigger: "30%"
    notes: "ADD to existing 66 shares. Brings position from 3.1% to ~6%."
    expiry: 2026-04-01


  - ticker: ZIG.L
    action: BUY
    trigger: "<=375 GBp"
    size_eur: 350
    shares_approx: 81
    thesis: thesis/research/ZIG.L/thesis.md
    fair_value: "652 GBp"
    mos_at_trigger: "42%"
    notes: "Zigup fleet management. v2.0 CONFIRMED. Tier B. 4-method valuation. ROCE 11.9% > WACC 8%."
    expiry: 2026-05-01

  # GL ADD - CONDITIONAL on price pullback
  - ticker: GL
    action: ADD
    trigger: "<=$130"
    size_eur: 300
    shares_approx: 2
    thesis: thesis/active/GL/thesis.md
    fair_value: "$174"
    mos_at_trigger: "25.3%"
    notes: "Globe Life. Framework v2.0 FV $174. At $130 reaches 25% MoS. Current $143 = 17.6% MoS (insufficient). Quality 7/10 Tier B."
    expiry: 2026-06-01

  # PENDIENTE EARNINGS - Ejecutar SOLO si earnings cumplen condiciones
  - ticker: EVO.ST
    action: BUY
    trigger: "<=600 SEK + UKGC favorable (fine/conditions, NOT revocation)"
    size_eur: 300
    shares_approx: 5
    thesis: thesis/research/EVO.ST/thesis.md
    fair_value: "950 SEK"
    fair_value_bear: "600 SEK"
    tier: "C (Regulatory Risk)"
    notes: "v2.0: Tier C por UKGC risk. Si UKGC revocacion - CANCELAR. Si favorable - BUY <=600 SEK."
    expiry: 2026-02-15

  - ticker: FGP.L
    action: BUY
    trigger: "<=165 GBp"
    size_eur: 400
    shares_approx: 209
    thesis: thesis/research/FGP.L/thesis.md
    fair_value: "220-240 GBp"
    mos_at_trigger: "25%"
    notes: "FirstGroup. v2.0 CONFIRMED. UK bus/rail. P/E 9x, Tier B. Narrow moat. IFRS16 distorts FCF. FV blended 220-230p (EV/EBIT + P/E). Value trap 2/10."
    expiry: 2026-06-01

  - ticker: BBWI
    action: BUY
    trigger: "<=$18.50"
    size_eur: 400
    shares_approx: 21
    thesis: thesis/research/BBWI/thesis.md
    fair_value: "$29"
    mos_at_trigger: "36%"
    notes: "Bath & Body Works. Tier C turnaround. $5B debt, negative equity. FCF $660M (14% yield). Monitor Q4 Feb 19."
    expiry: 2026-04-01

  - ticker: CMCSA
    action: BUY
    trigger: "<=$26"
    size_eur: 450
    shares_approx: 15
    thesis: thesis/research/CMCSA/thesis.md
    fair_value: "$33-38"
    mos_at_trigger: "26-31%"
    notes: "Comcast. Tier B. Broadband declining, theme parks star. $95B net debt. P/E 5.5x misleading (fwd 7.5x). Watch broadband losses."
    expiry: 2026-06-01

  - ticker: WPP.L
    action: BUY
    trigger: "<=200 GBp"
    size_eur: 400
    shares_approx: 173
    thesis: thesis/research/WPP.L/thesis.md
    fair_value: "380 GBp"
    mos_at_trigger: "47%"
    notes: "WPP turnaround. Tier C. No moat, AI disruption. Altman Z 1.06. Wait for Rose plan Feb 19."
    expiry: 2026-04-01

  # NVO ADD - CONDITIONAL on CagriSema data or price drop
  - ticker: NVO
    action: ADD
    trigger: "CagriSema vs Zepbound POSITIVE (March 2026) OR price <=$40"
    size_eur: 300
    shares_approx: 6
    thesis: thesis/active/NVO/thesis.md
    fair_value: "$66 (DKK 491)"
    mos_at_trigger: "40%+ at $40"
    notes: "ADD to existing 8.31 shares. Brings position from 4% to 6-7%. Framework v3.0 Tier A."
    expiry: 2026-06-01

  # MA - Quality Compounder waiting for entry
  - ticker: MA
    action: BUY
    trigger: "<=$395"
    size_eur: 500
    shares_approx: 1.3
    thesis: thesis/research/MA/thesis.md
    fair_value: "$420"
    mos_at_trigger: "6% at $395, better at lower"
    tier: "A (QS 86)"
    notes: "Quality Compounder (ROIC 44%, FCF 48%). Currently $551 = OVERVALUED. Wait for correction. P/E 33x → need ~24-28x."
    expiry: 2026-08-01

  # V - Quality Compounder waiting for entry
  - ticker: V
    action: BUY
    trigger: "<=$280"
    size_eur: 500
    shares_approx: 1.8
    thesis: thesis/research/V/thesis.md
    fair_value: "$275-290"
    mos_at_trigger: "3-5% at $280, better at $265"
    tier: "A (QS 80)"
    notes: "Quality Compounder (ROIC 50%+, FCF 54%, #1 market share 52%). Currently $329 = OVERVALUED. V closer to entry than MA (-15% vs -28%)."
    expiry: 2026-08-01

  - ticker: V
    action: ADD
    trigger: "<=$265"
    size_eur: 300
    shares_approx: 1.1
    thesis: thesis/research/V/thesis.md
    fair_value: "$275-290"
    mos_at_trigger: "8-10% at $265"
    tier: "A (QS 80)"
    notes: "ADD to existing position if price drops further. Total target 5-6%."
    expiry: 2026-08-01

# -----------------------------------------------------------------------------
# MACRO (resumen)
# -----------------------------------------------------------------------------
macro_snapshot:
  last_update: 2026-02-02
  themes: ["Fed/BCE pausa 3.5%/2.0%", "Europa barata", "Tariffs escalando (Corea 25%, Canada amenaza)", "Iran tension up", "China mejora IMF 4.5%", "Alemania sale recesion"]
  risks: ["US-Iran guerra regional 30-40% (up)", "US-China Taiwan 10-20%", "Tariff war global 40-50%", "Recesion US 25-35%", "Oil shock >$90 si Iran 15-25%"]

# -----------------------------------------------------------------------------
# MANTENIMIENTO
# -----------------------------------------------------------------------------
maintenance:
  last_health_check: 2026-02-04
  next_health_check_due: 2026-02-18
  health_score: 9.1/10
  health_check_issues:
    - severity: WARNING
      issue: "Falta sector view energy.md - SHEL.L es posicion activa sin cobertura"
      action: "Crear world/sectors/energy.md"
    - severity: WARNING
      issue: "CLAUDE.md 752 lineas (>150 limite)"
      action: "Considerar compactacion/extraction a skills si sigue creciendo"
    - severity: INFO
      issue: "LIGHT.NV vs LIGHT.AS ticker inconsistencia en transacciones"
      action: "Normalizar a LIGHT.AS"
  last_compact: 2026-02-01
  memory_status: ok
  agents_count: 20  # Added opportunity-hunter
  skills_count: 18
  tools_count: 7
  evolution_tracking:
    last_evaluation: 2026-02-03
    applied:
      - "2026-02-01: Fusion self-evolution+evolution-manager - system-evolver"
      - "2026-02-01: health-check upgraded haiku-sonnet, +quantitative checks"
      - "2026-02-01: TTE moved active-watchlist"
      - "2026-02-01: system.yaml compacted 863-~350 lines"
    applied_2026_02_04_health_check:
      - "Health check ejecutado: score 9.1/10"
      - "WARNING: Falta energy.md sector view"
      - "WARNING: CLAUDE.md >150 lineas (752)"
      - "INFO: LIGHT.NV/AS ticker inconsistencia"
      - "19 agentes OK, 18 skills OK, 7 tools OK"
      - "18 posiciones = 18 thesis OK"
      - "Sector views: 10/11 sectores cubiertos"
    applied_2026_02_03_utg_review:
      - "UTG.L re-evaluated with v2.0 framework: VALIDATED"
      - "Standing order at 540 GBp MAINTAINED"
      - "FV updated: 745 GBp (was 770 GBp) - weighted expected value more conservative"
      - "MoS at 540p = 27.5% (passes 25% Tier B threshold)"
      - "Value trap checklist: 1.5/10 (PASS)"
      - "Narrow moat via Efficient Scale (near-monopoly UK listed PBSA)"
      - "Multi-method valuation: NAV (40%), DDM (30%), FFO Multiple (30%)"
      - "Bear/Base/Bull scenarios: 610p/745p/870p"
      - "Key risk: Immigration policy reducing international student demand"
      - "Earnings Feb 24: watch occupancy guidance FY2027/28"
      - "Thesis v2.0 created: thesis/research/UTG.L/thesis_v2.md"
    applied_2026_02_03_hpq_review:
      - "HPQ re-evaluated with v2.0 framework: REJECTED as value trap"
      - "4/10 value trap factors: secular decline, digital disruption, negative equity, insider selling"
      - "MoS 22% vs 35% required for Tier C quality score 5/10"
      - "Standing order at $18.50 ELIMINATED"
      - "Thesis moved to thesis/archive/HPQ/thesis.md"
    applied_2026_02_03_session25:
      - "Re-evaluacion PFE: FV $27.52 (era $32-35), MoS 3-10% (era 25-36%) - FAIRLY VALUED"
      - "Re-evaluacion ALL: FV $240 (confirmado), MoS 16% (era 21%) - MODERATELY UNDERVALUED"
      - "Re-evaluacion SHEL.L: FV L26.8 (era L32-35), MoS -4% (era 25-30%) - FAIRLY VALUED"
      - "Re-evaluacion GL: FV $174 (era $215), MoS 17.6% (era 34%) - HOLD (was BUY). P/B vs ROE method."
      - "Framework v2.0 es ~20pp mas conservador que analisis original"
    applied_2026_02_02:
      - "Fixed SHEL-SHEL.L ticker bug (+$427 phantom value)"
      - "Fixed dcf_calculator.py GBp/GBP mismatch for LSE stocks"
      - "Portfolio fully synced with eToro (13 positions)"
